Gland Pharma IPO Synopsis

Gland Pharma IPO-Date, Review and Details

05/11/2020 CA Priyanka Choudhary Jain 0

Gland Pharma has robust business model and strong financial performance since 2017 when Fosun took over major stake; post IPO its stake would come down to 58%. The IPO is worth investing if the geopolitical tension remains subdued. However investors wary of external risk may consider investing based on their risk appetite.

Fatal error: Uncaught Error: Call to undefined function WP_Optimize() in /var/www/wp-content/plugins/wp-optimize/cache/file-based-page-cache-functions.php:164 Stack trace: #0 [internal function]: wpo_cache('<!DOCTYPE html>...', 9) #1 /var/www/wp-includes/functions.php(4673): ob_end_flush() #2 /var/www/wp-includes/class-wp-hook.php(287): wp_ob_end_flush_all('') #3 /var/www/wp-includes/class-wp-hook.php(311): WP_Hook->apply_filters(NULL, Array) #4 /var/www/wp-includes/plugin.php(478): WP_Hook->do_action(Array) #5 /var/www/wp-includes/load.php(1007): do_action('shutdown') #6 [internal function]: shutdown_action_hook() #7 {main} thrown in /var/www/wp-content/plugins/wp-optimize/cache/file-based-page-cache-functions.php on line 164

FinancePost

Updates You Can Bank On

Gland Pharma IPO Synopsis

Gland Pharma IPO-Date, Review and Details